Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001209191-19-041241

Options or other derivatives

  • Director acquired 350,947 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MOTT DAVID M Director 2019-07-02 Grant or award · Option to purchase Ordinary Shares +350,947 350,947 D
Loading xslF345X03/doc4.xml…